Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.21.2
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Accounts payable:    
Clinical and regulatory expenses $ 335 $ 262
Professional fees 343 252
Selling expenses 436 395
Manufacturing costs 14 596
Other vendors 200 518
Total accounts payable 1,328 2,023
Accrued interest payable, related parties 65 41
Accrued interest payable 383 627
Accrued expenses:    
Payroll expenses 1,075 1,053
Government rebates and other rebates 2,337 2,659
Due to EJ Holdings 427 545
Other accrued expenses 686 512
Total accrued expenses 4,525 4,769
Total accounts payable and accrued expenses $ 6,301 $ 7,460